HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timothy McAfoos Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

11/2020Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Timothy McAfoos Research Topics

Disease

4Neoplasms (Cancer)
10/2021 - 01/2018
1Sarcoma (Soft Tissue Sarcoma)
10/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Brain Neoplasms (Brain Tumor)
01/2018
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018

Drug/Important Bio-Agent (IBA)

1Mitogen-Activated Protein KinasesIBA
10/2021
1compound 30IBA
10/2021
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2021
1Glutamine (L-Glutamine)FDA Link
11/2020
1Tyrosine Kinase InhibitorsIBA
11/2020
1osimertinibIBA
11/2020
1NucleotidesIBA
01/2018
1IACS-010759IBA
01/2018
1Aspartic Acid (Aspartate)FDA Link
01/2018

Therapy/Procedure

2Therapeutics
10/2021 - 11/2020